As breast cancer is related to hormone and has different molecular types, we further divided patients into five separate subgroups based on molecular subtype, Ki67 status, ER status, PR status, and HER2 status to analyze the correlation between GLYAT expression and prognosis of breast cancer. The gene discussed is MKI67; the disease is breast carcinoma.